Prioritizing Post-Testing Healthcare for Disease Sufferers in Nigeria

Nigeria faces challenges in providing post-testing healthcare for high-profile diseases, leading to stigma, reduced productivity, and uncontrolled disease spread. Prioritizing comprehensive support and reducing stigma is crucial to improve outcomes and control disease.

author-image
Nasiru Eneji Abdulrasheed
Updated On
New Update
Prioritizing Post-Testing Healthcare for Disease Sufferers in Nigeria

Prioritizing Post-Testing Healthcare for Disease Sufferers in Nigeria

Nigeria faces significant challenges in providing adequate post-testing healthcare for individuals suffering from high-profile diseases (HPDs) such as HIV/AIDS, SARS, COVID-19, sickle cell anemia, tuberculosis, cancer, and Alzheimer's. These diseases often carry a stigma, leading affected individuals to hide their condition and disappear from public view, according to a recent article.

The lack of comprehensive counseling, encouragement, and follow-up care for HPD sufferers results in many not receiving the necessary treatment and support. This not only affects the individuals but also has broader implications for the nation, including reduced productivity, more avoidable deaths, and the uncontrolled spread of diseases.

Why this matters: Prioritizing post-testing healthcare for HPD sufferers is crucial for improving their chances of survival and productivity, as well as controlling the spread of diseases in Nigeria. Addressing this issue requires a concerted effort from the healthcare system and society to provide comprehensive support and reduce the stigma associated with these conditions.

The article emphasizes the need for the Nigerian healthcare system and society to prioritize the post-testing healthcare needs of people with HPDs. This includes providing them with counseling and support, ensuring they continue with their treatment, and offering tailored healthcare services to ensure the best possible outcomes, especially for those with weakened immune systems.

The importance of prioritizing post-testing healthcare for disease sufferers is further highlighted by the development of survivorship care programs in other countries. For example, the BETER program in the Netherlands aims to reduce the burden of disease from late adverse events in Hodgkin lymphoma survivors through risk-based screening and timely intervention.

The COVID-19 pandemic has also had a significant impact on healthcare services beyond the direct treatment of the disease. A study in Finland showed a decrease in physical in-person primary care appointments and an increase in digital care channels during the pandemic. This shift contributed to a decrease in the utilization of diagnostic and imaging services, underscoring the need for comprehensive healthcare planning and pandemic preparedness.

The article stresses the importance of providing comprehensive and tailored healthcare services to ensure the best possible outcomes for HPD sufferers in Nigeria. This includes offering counseling, encouragement, and follow-up care to ensure individuals continue with their treatment and receive the necessary support. By prioritizing the post-testing healthcare needs of HPD sufferers, Nigeria can improve their chances of survival and productivity while also controlling the spread of diseases in the country.

Key Takeaways

  • Nigeria faces challenges in providing adequate post-testing healthcare for HPD sufferers.
  • Lack of counseling, encouragement, and follow-up care leads to poor treatment and disease spread.
  • Prioritizing post-testing healthcare for HPD sufferers is crucial for improving survival and productivity.
  • Comprehensive support and reduced stigma are needed to address this issue in Nigeria.
  • Pandemic-related healthcare changes highlight the need for comprehensive planning and preparedness.